-
1
-
-
0026093615
-
Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock like state and tissue injury in rabbits without endotoxemia: Comparison to Escherichia coli
-
Wakabayashi G, Gelfard JA, Jung WK, et al: Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock like state and tissue injury in rabbits without endotoxemia: Comparison to Escherichia coli. J Clin Invest 1991; 87:1925-1935
-
(1991)
J Clin Invest
, vol.87
, pp. 1925-1935
-
-
Wakabayashi, G.1
Gelfard, J.A.2
Jung, W.K.3
-
2
-
-
0027731546
-
Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome
-
Casey LC, Balk RA, Bone RC: Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
-
(1993)
Ann Intern Med
, vol.119
, pp. 771-778
-
-
Casey, L.C.1
Balk, R.A.2
Bone, R.C.3
-
3
-
-
0028873514
-
Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in human
-
Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in human. J Infect Dis 1995; 171:145-152
-
(1995)
J Infect Dis
, vol.171
, pp. 145-152
-
-
Kuhns, D.B.1
Alvord, W.G.2
Gallin, J.I.3
-
4
-
-
0024520830
-
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock
-
Natanson C, Eichenholz PW, Danner RL, et al: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823-832
-
(1989)
J Exp Med
, vol.169
, pp. 823-832
-
-
Natanson, C.1
Eichenholz, P.W.2
Danner, R.L.3
-
5
-
-
0027417688
-
Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients
-
Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21:522-526
-
(1993)
Crit Care Med
, vol.21
, pp. 522-526
-
-
Bellomo, R.1
Tipping, P.2
Boyce, N.3
-
6
-
-
0030052232
-
Plasmapheresis in severe sepsis or septic shock
-
Stegmayr BG: Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996; 14:94-101
-
(1996)
Blood Purif
, vol.14
, pp. 94-101
-
-
Stegmayr, B.G.1
-
7
-
-
18744402182
-
Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: Clinical results of a pilot study
-
Bengsch S, Boos KS, Nagel D, et al: Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: Clinical results of a pilot study. Shock 2005; 23:494-500
-
(2005)
Shock
, vol.23
, pp. 494-500
-
-
Bengsch, S.1
Boos, K.S.2
Nagel, D.3
-
8
-
-
3943092597
-
Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis
-
Reinhart K, Meier-Hellmann A, Beale R, et al: Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Crit Care Med 2004; 32:1662-1668
-
(2004)
Crit Care Med
, vol.32
, pp. 1662-1668
-
-
Reinhart, K.1
Meier-Hellmann, A.2
Beale, R.3
-
9
-
-
20244379132
-
A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intraabdominal infection
-
Vincent JL, Laterre PF, Cohen J, et al: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intraabdominal infection. Shock 2005; 23:400-405
-
(2005)
Shock
, vol.23
, pp. 400-405
-
-
Vincent, J.L.1
Laterre, P.F.2
Cohen, J.3
-
10
-
-
1542719614
-
Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kB DNA binding, and improves short-term survival in lethal endotoxemia
-
Kellum JA, Song M, Venkataraman R: Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004; 32:801-805
-
(2004)
Crit Care Med
, vol.32
, pp. 801-805
-
-
Kellum, J.A.1
Song, M.2
Venkataraman, R.3
-
11
-
-
11244349785
-
Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: An in vitro study
-
Oda S, Hirasawa H, Shiga H, et al: Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study. Blood Purif 2004; 22:530-536
-
(2004)
Blood Purif
, vol.22
, pp. 530-536
-
-
Oda, S.1
Hirasawa, H.2
Shiga, H.3
-
12
-
-
0027858811
-
A new treatment for dialysis-related amyloidosis with beta2-microglobulin adsorbent column
-
Nakazawa R, Azuma N, Suzuki M, et al: A new treatment for dialysis-related amyloidosis with beta2-microglobulin adsorbent column. Int J Artif Organs 1993; 16:823-829
-
(1993)
Int J Artif Organs
, vol.16
, pp. 823-829
-
-
Nakazawa, R.1
Azuma, N.2
Suzuki, M.3
-
13
-
-
0031672461
-
Lixelle adsorbent to remove inflammatory cytokines
-
Tsuchida K, Takemoto Y, Nakamura T, et al: Lixelle adsorbent to remove inflammatory cytokines. Artif Organs 1998; 22:1064-1067
-
(1998)
Artif Organs
, vol.22
, pp. 1064-1067
-
-
Tsuchida, K.1
Takemoto, Y.2
Nakamura, T.3
-
14
-
-
0033868829
-
Adsorption of microorganism components by lixelle beads
-
Tsuchida K, Takemoto Y, Nakatani T, et al: Adsorption of microorganism components by lixelle beads. Artif Organs 2000; 24:577-580
-
(2000)
Artif Organs
, vol.24
, pp. 577-580
-
-
Tsuchida, K.1
Takemoto, Y.2
Nakatani, T.3
-
15
-
-
0036013440
-
Adsorption of endotoxin by beta2-microglobulin adsorbent column (Lixelle): The new approach for endotoxinemia
-
Tsuchida K, Takemoto Y, Sugimura K, et al: Adsorption of endotoxin by beta2-microglobulin adsorbent column (Lixelle): The new approach for endotoxinemia. Ther Apher 2002; 6:116-118
-
(2002)
Ther Apher
, vol.6
, pp. 116-118
-
-
Tsuchida, K.1
Takemoto, Y.2
Sugimura, K.3
-
16
-
-
18744366323
-
Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis
-
Hiyama E, Hyodo T, Kondo M, et al: Performance of the newer type (Lixelle Type S-15) on direct hemoperfusion beta-2-microglobulin adsorption column for dialysis-related amyloidosis. Nephron 2002; 92:501-502
-
(2002)
Nephron
, vol.92
, pp. 501-502
-
-
Hiyama, E.1
Hyodo, T.2
Kondo, M.3
-
17
-
-
0034056458
-
Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats
-
Taniguchi T, Yamamoto K, Ohmoto N, et al: Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000; 28:1101-1106
-
(2000)
Crit Care Med
, vol.28
, pp. 1101-1106
-
-
Taniguchi, T.1
Yamamoto, K.2
Ohmoto, N.3
-
18
-
-
0034796597
-
Ketamine inhibits endotoxin-induced shock in rats
-
Taniguchi T, Shibata K, Yamamoto K: Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 2001; 95:928-932
-
(2001)
Anesthesiology
, vol.95
, pp. 928-932
-
-
Taniguchi, T.1
Shibata, K.2
Yamamoto, K.3
-
19
-
-
2942565800
-
Effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats
-
Taniguchi T, Kidani Y, Kanakura H, et al: Effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004; 32:1322-1326
-
(2004)
Crit Care Med
, vol.32
, pp. 1322-1326
-
-
Taniguchi, T.1
Kidani, Y.2
Kanakura, H.3
-
20
-
-
29144472369
-
A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis
-
Saotome T, Endo Y, Sasaki T, et al: A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis. Ther Apher Dial 2005; 9:367-371
-
(2005)
Ther Apher Dial
, vol.9
, pp. 367-371
-
-
Saotome, T.1
Endo, Y.2
Sasaki, T.3
-
21
-
-
0030746482
-
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
-
Zeni F, Freeman B, Natanson C: Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med 1997; 25:1095-1100
-
(1997)
Crit Care Med
, vol.25
, pp. 1095-1100
-
-
Zeni, F.1
Freeman, B.2
Natanson, C.3
-
22
-
-
0029900294
-
Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein: the Soluble TNF Receptor Sepsis Study Group
-
Fisher CJ Jr, Agosti JM, Opal SM, et al: Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein: The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996; 334:1697-1702
-
(1996)
N Engl J Med
, vol.334
, pp. 1697-1702
-
-
Fisher Jr., C.J.1
Agosti, J.M.2
Opal, S.M.3
-
23
-
-
0027920980
-
Pathogenetic mechanisms of septic shock
-
Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1991; 328:1471-1477
-
(1991)
N Engl J Med
, vol.328
, pp. 1471-1477
-
-
Parrillo, J.E.1
-
24
-
-
0030843156
-
Sepsis: A new hypothesis for pathogenesis of the disease process
-
Bone RC, Grodzin CJ, Balk RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-243
-
(1997)
Chest
, vol.112
, pp. 235-243
-
-
Bone, R.C.1
Grodzin, C.J.2
Balk, R.A.3
-
26
-
-
0347364687
-
Organism-specific neutrophil-endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus
-
Moreland JG, Bailey G, Nauseef WM, et al: Organism-specific neutrophil-endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. J Immunol 2004; 172:426-32
-
(2004)
J Immunol
, vol.172
, pp. 426-432
-
-
Moreland, J.G.1
Bailey, G.2
Nauseef, W.M.3
-
27
-
-
0025332660
-
Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration
-
Salyer JL, Bohnsack JF, Knape WA, et al: Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration. Am J Pathol 1990; 136:831-841
-
(1990)
Am J Pathol
, vol.136
, pp. 831-841
-
-
Salyer, J.L.1
Bohnsack, J.F.2
Knape, W.A.3
|